Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-13

Clinical Trial Update: Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing topical tazarotene 0.1% gel to microneedling for atrophic acne scars has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microneedling
  • Tazarotene 0.1% gel (tazarotene)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Acne Scar | Phase 2, Phase 3 | Status: COMPLETED